169 related articles for article (PubMed ID: 1908493)
1. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
[TBL] [Abstract][Full Text] [Related]
2. Interaction of L-dopa and GHRH on GH secretion in normal men.
Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K
J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
[TBL] [Abstract][Full Text] [Related]
3. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.
Giusti M; Lomeo A; Mazzocchi G; Torre R; Monachesi M; Sessarego P; Attanasio R; Giordano G
J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459
[TBL] [Abstract][Full Text] [Related]
4. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
5. [Prolactin response to acute administration of growth hormone releasing hormone in patients with uremia].
García Martín F; Donnay Candil S; Martín Escobar E; Alvaro R; de Arriba G; Requejo R; Martín Hernández R
Rev Clin Esp; 1989 Nov; 185(8):399-401. PubMed ID: 2516347
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
Zanoboni A; Gibillini M; Cucchi MR; Zanoboni Muciaccia W; Zanussi C
J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
8. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
9. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
10. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
Díez JJ; Iglesias PL; Sastre J; Gómez-Pan A; Selgas R; Martínez-Ara J; Miguel JL; Méndez J
Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
[TBL] [Abstract][Full Text] [Related]
11. A re-evaluation of the prolactin-releasing activity of growth hormone-releasing hormone in acromegaly in vivo.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):73-8. PubMed ID: 7746357
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
Jin J; Hashizume T
Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
[TBL] [Abstract][Full Text] [Related]
13. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
Giusti M; Lomeo A; Torre R; Sghedoni D; Mazzocchi G; Durante R; Giordano G
Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
15. The interaction of GHRH with TRH in acromegaly: a controlled study.
Looij BJ; Roelfsema F; Frölich M; Nieuwenhuijzen Kruseman AC
Acta Endocrinol (Copenh); 1991 Oct; 125(4):337-41. PubMed ID: 1957553
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
17. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
18. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
20. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
